The gastrointestinal tract forms the largest surface in our body with constantly being exposed to various antigens, which provides unique microenvironment for the immune system in the intestine. Accordingly, the gut epithelium harbors the most T lymphocytes in the body as intraepithelial lymphocytes 
INTRODUCTION
The intestine is the biggest immunological organ in our body with its huge surface that is constantly exposed to foreign matters, such as food and pathogens (1) . There is a delicate balance between protective immunity against detrimental pathogens and tolerance to food and beneficial bacteria. To keep the homeostatic balance, various immune cells are located in the gut epithelial lining. Among the immune cells, lymphocytes located within the gut epithelium are intestinal intraepithelial lymphocytes (IELs), which represent the largest heterogeneous T cell population in the organisms. Due to the constant exposure of antigens at the mucosal barrier, IELs have unique and antigen-experienced activated phenotypes, constitutively expressing CD8 homodimer, CD8, and CD103 (E integrin), distinct from the conventional T cells in the periphery. Further, they are suggested to play a pivotal role in providing protective immunity as the first line of immune defense (reviewed in .
In this review, we discuss the development, subtypes, and functions of IELs, especially focusing on the unusual CD4 IELs expressing CD8 homodimer, CD4CD8 double positive (DP) IELs. There are decent reports recently revealed that conventional CD4 T cells post-thymically reprogram to cytotoxic T lymphocyte (CTL)-like DP IELs expressing CTL-lineage associated genes in the gut microenvironment (5, 6 ). We focus on how conventional CD4 T cells in the periphery reprogram their cellular fate from the T helper lineage to the CTL-like DP IELs in the gut environment.
SUBSETS OF IELS
IELs can be classified into "natural" and "induced" categories based on their developmental origin and co-receptor expressions (2) (3) (4) . Natural IELs (nIELs), previously classified as "type b" IELs, differentiate unconventionally from their own precursors and are activated during selection process in response to self-antigens in the thymus. They are barely detectable in peripheral mainstream lymphoid tissues and express either  T cell receptor (TCR) or  TCR with a unique co-receptor, CD8, without conventional CD4 or CD8 co-receptors (CD8 TCR IELs or CD8 TCR IELs). Induced IELs (iIELs), previously "type a IELs", are derived from the conventional CD4 or CD8 T cells in the periphery and postthymically differentiated in the intestine. They are  TCRbearing CD4 or CD8 T cells with a predominance of CD8 T cells, which have much in common with conventional CD4 and CD8 T cells found in the spleen and other lymphoid Invited Mini Review http://bmbreports.org 
CD8
＋ triple positive (TP) cells, which go through a self antigen-based thymic selection process ("agonist selection"). On the other hand, induced IELs (iIELs) are derived from the circulating conventional CD4 or CD8 T cells, which further undergo post-thymic differentiation process.
tissues. These conventional iIELs also co-express CD8 together with CD4 or CD8, thus the expression of CD8 is a hallmark of IEL populations in the gut epithelium (2-4).
UNIQUE DEVELOPMENT OF IELS
Originally, nIELs are thought to differentiate thymus-independently. Early experiment described that thymectomy has little effects on the generation of IELs in the intestine (7), and CD8 IELs are present in neonatally thymectomized mice reconstituted with bone marrow or fetal liver (8-10). Studies show that cryptopatches (CP) in the small intestine contain IEL precursor cells (11, 12) , and that CP cells from nude mice are able to reconstitute IELs (12), further supporting the idea that nIELs are derived extra-thymically from CP precursors. However, increasing evidence supports the importance of thymus and thymic progenitors for nIEL development. It has been reportedly observed that the number of CD8 IELs is extremely reduced in athymic mice (9, 13, 14), indicating that thymus is functional for nIEL development. Moreover, a genetic fate mapping study showed direct evidence that all CD8-bearing  TCR IELs originate from CD4 ＋
CD8
＋ DP thymocytes rather than CP precursors (15). The thymic development of nIELs is further clarified by the identification of thymic precursors of CD8 IELs. Cheroutre and co-workers discovered that CD4
＋ triple positive (TP) cells in the thymus, distinct from classical CD4 ＋
CD8
＋ DP thymocytes, are unique precursors for CD8 IELs, which are selected and matured in a "alternative" way by strong interactions with self-antigens, termed "agonist selection" (16) (Fig. 1) . As a result, they become mature, memory-like CD4
−

CD8
−  or TCR-expressing T cells and acquire gut-homing capacity in the thymus, thereby directly migrating to the intestinal epithelium (16, 17).
Contrary to nIELs, iIELs are the progeny of conventional MHC class I-restricted CD8 or MHC class II-restricted CD4 naïve T cells that further undergo post-thymic differentiation process in the intestine (reviewed in ref [2] [3] [4] . Naïve T cells are activated in response to antigens in the periphery, particularly gut-associated lymphoid tissue (GALT), including Peyer's patches (PPs) and mesenteric lymph nodes (MLN), and then migrate into the intestinal epithelium to become iIELs. It is well known that CD103
＋ dendritic cells (DCs) in the GALT with their ability to produce the vitamin A metabolite, retinoic acid (RA), confer the gut-homing capacity to naïve T cells they prime (18, 19) . RA induces gut-homing receptors, 47 and CCR9 on T cells, which bind to mucosal adhesion molecule 1 (MAdCAM-1) and CCL25, respectively (20). These are constitutively expressed on small intestinal endothelium and epithelium, thus directing T cells to traffic into the intestine (21-23). In the intestine, T cells subsequently down-regulate 4 subunit of 47 and gradually acquire E (CD103) expression to form integrin E7 (24, 25), which is induced by transforming growth factor (TGF)- in the gut environment (26). E7 is a major adhesion molecule, which mediates selective localization or retention of IELs to the epithelial compartment of the intestine by interacting with E-cadherin expressed on the basolateral surface of enterocytes (27).
FUNCTIONS OF IELS
The precise physiological functions of IELs are not still clear. Yet, their strategic location at the front line of defense and concomitant expression of effector and regulatory molecules allows us to predict that these cells are of importance for controlling pathogen infection and preserving the integrity of epithelial barrier in the gut. Although CD8 TCR IELs are self-reactive and cytotoxic effectors with high granzyme B ex-13 http://bmbreports.org BMB Reports pression (3), they are not self-destructive, and instead they have been shown to mediate immune regulation by expressing several regulatory molecules including interleukin-10 (IL-10), TGF- and lymphocyte activation gene 3 (LAG 3) (28, 29). In a mouse model of induced colitis, self-specific CD8 TCR IELs exert a regulatory function by controlling the migration and activity of pathogenic CD4 T cells in the intestine (28). Nevertheless, it is still possible that these self-reactive CD8 TCR IELs may drive autoimmune pathology under inflammatory or damaged conditions (4) . TCR IELs also contribute to protective immunity, secreting TNF and IFN- (30) and keep gut integrity through producing TGF-1, TGF-3 and keratinocyte growth factor (KGF) to repair epithelial damage (31). CD8TCR IELs are reported to serve as long-residing effector memory cells within the epithelium to provide protection against various invading pathogens, including simian immunodeficiency virus (SIV) (32, 33), lymphocyte choriomeningtis virus (LCMV) (34), and rotavirus (35). Studies suggest that CD4 IELs, though a minor subset compared to natural or CD8 TCR IELs, may contribute to the prevention of immunopathology in the intestine by exerting their protective and regulatory functions (36, 37). Two important reports recently identified CD4 CTLs as a distinct subset of effector CD4 T cells, which express co-receptor CD8 and CTL lineage genes distinguishing them from any other conventional CD4 T helper subsets or regulatory T cells (5, 6) . At steady state, these cytotoxic CD4 T cells are mostly found in the small intestine as CD4CD8 double positive (DP) IELs (42) and can be experimentally generated in the T cell transfer model of colitis, in which naïve T cells are transferred into lymphopenic hosts (5, 6) . Remarkably, these reports show that the cytotoxic DP IELs lack ThPOK, the master transcription factor for CD4 Th lineage commitment, of which expression is maintained highly in the peripheral conventional CD4 T cells and critical for their helper functions. DP IELs are initially originated from conventional CD4 
CD4CD8 IELS
ThPOK-Runx3: MASTER TRANSCRIPTIONAL REGULATORS FOR CD4CD8IEL DEVELOPMENT
The co-receptor expression of either CD4 or CD8 is precisely correlated with T cell function as helper or killer T cells, respectively. Therefore, this lineage decision process from CD4 ＋
CD8
＋ DP thymocytes to either lineage is crucial in T cell biology and extensively studied over the decades. With the identification of the ThPOK transcription factor (43, 44) and its counteraction with Runx3 (45), it is now widely accepted that this key developmental decision is made at the transcriptional level.
ThPOK is a key transcription regulator, which drives CD4
＋ thymocytes to become mature CD4 T cells, and Runx3 is required for CD8 T cell development (46, 47). The fate decision of helper or CTL is driven by the antagonistic interaction between these two transcription factors, as ThPOK is highly expressed and maintained in mature CD4 T cells in the periphery, preventing Runx3-mediated CTL program. On the other hand, Runx3 expression is preferentially up-regulated during CD8 lineage differentiation in the thymus and remains high in mature CD8 T cells, which represses ThPOK expression by binding to silencer of ThPOK gene in immature CD8 thymocytes (46, 47). In addition to silencing CD4 by repressing ThPOK, Runx3 also reactivates CD8 by directly binding to Cd8 enhancer, E8I, of the CD8 gene locus (48).
It has long been thought that CD4-CD8 lineage commitment is mutually exclusive and irreversible. Although mature CD4 T cells are able to differentiate into separate subtypes of helper T cells in response to peripheral antigens, such Th1, Th2, Th17, and regulatory T cells, they maintain their ThPOK expression and helper lineage gene profiles (5, 49) . Therefore, little progress has been made in the study of CD8-expressing cytotoxic CD4 T cells in terms of lineage reprogramming despite their existence in the gut and other tissues during viral infection. Recently, two groundbreaking studies bring a new concept of plasticity of mature CD4 T cell development, revealing that CD4 T cells can reprogram to cytotoxic CD8 lineage-like cells, CD4CD8 T cells, in the small intestine in response to cognate antigens by losing their ThPOK expression, which is mediated by Runx3 up-regulation in the specific gut environment (5, 6).
Mucida et al. (5) found that CD4CD8DP IELs, the most observed cytotoxic CD4 T cells, lack ThPOK expression, which is normally expressed high in the conventional CD4 T cells in the periphery. Concomitantly, DP IELs display cytotoxic phenotypes like CD8 CTLs, including high expression of granzyme B and the activation-induced degranulation marker CD107a. By using well-designed fate-mapping mouse model, they showed that these cells are derived from ThPOK ＋ CD4 T cells, which lose their ThPOK expression after activa-http://bmbreports.org 
T-bet AS A SWITCH FOR CD4CD8 IEL DEVELOMENT
Subsequently, Reis et al. (50) also reported that transcription factor, T-bet (T-box expressed in T cells), is a critical upstream regulator of Runx3 and ThPOK in the development of cytotoxic CD4CD8 DP IELs. T-bet is a well-known transcription factor for Th1 differentiation and CD8 T cells for their IFN- production, whereas inhibiting the development of other T helper subtypes. They found that the expression of Tbx21 encoding T-bet is up-regulated in ThPOK lo IELs, and DP IEL differentiation is impaired in T-bet-deficient CD4 T cells, comparable to Runx3 −/− CD4 T cells. In the presence of gut microenvironmental cues, such as TGF- and RA, and T-bet inducing cytokines in the intestinal milieu, such as IFN- or IL-27, preferentially induce cytotoxic CD4CD8 DP IEL differentiation by inducing Runx3 and suppressing ThPOK expression. Notably, these combinations suppress TGF-/RA-mediated Foxp3 induction and T-bet-mediated Th1 differentiation, suggesting a distinct role of T-bet in the CD4CD8 DP IEL development.
Interestingly, overexpression of T-bet in the absence of Runx3 suppresses Th17 differentiation, and T-bet prevents Foxp3 induction regardless of Runx3 expression, suggesting that T-bet inhibits other CD4 T cell subsets in a Runx3-independent manner. A series of experiments using genetically modified CD4 T cells as well as chromatin immunoprecipitation (ChIP) analysis indicate that T-bet directly binds to the -39 kb and the -17 kb Runx3 regulatory elements and induces Runx3 expression. T-bet also binds to ThPOK regulatory binding sites to down-modulate ThPOK expression in a Runx3-dependent manner. Collectively, this study suggests that T-bet that is induced by gut environmental factors serves as an upstream regulator for Runx3 induction thereby promoting CD4CD8 DP IEL development. Yet once Runx3 expression is induced, T-bet and Runx3 have complementary roles in ThPOK down-regulation and cytotoxic DP IEL generation (Fig. 2) .
FUNCTIONS OF CD4CD8 IELS
Although DP IELs are equipped with cytotoxic properties since their development, DP IELs do not exert CTL function immediately and instead stay immunologically quiescent at steady state. Antigen-specific CD4CD8 DP IELs, as generated by transferring OVA-specific OT-II cells into immunodeficient recipients following OVA-feeding, remain immunologically inactive even in the continuous presence of cognate dietary antigens, though they possess cytotoxic potential (5) . This in-http://bmbreports.org BMB Reports dicates that DP IELs are "activated yet resting" like other IEL subsets, which is confirmed by increased uptake of thymidine analog BrdU and week signals of cell-cycle marker Ki67 (5). Upon exposure to inflammatory IL-15 with cognate antigens, however, diet-induced DP IELs become immunologically active, producing great amounts of IFN- and TNF and up-regulation of CD107a expression, implying the pathogenic potential of cytotoxic DP IELs (5). On the other hand, Reis et al. showed the plasticity of CD4CD8 T cells in their functional aspects (6). In a T cell-transfer model of colitis, ThPOK deletion in CD4 T cells, which enhance the generation of CD4CD8 T cells, coincides with reduced intestinal inflammation, suggesting non-pathogenic function of DP IELs. In line with this, mice receiving Runx3-deficient CD4 T cells accelerate colitis, which is associated with reduced CD4CD8 T cells, but increased Th17 differentiation. Mice deficient for CD4-specific Runx3 also develop more pathogenic Th17 cells with increased inflammation and tissue damage compared to control mice after Citrobacter rodentium infection; however, they are more efficient at clearing C. rodentium than the wild-type control (6). These results suggest that two facet of inflammation, protection and tissue damage, can be modulated at the transcriptional level by Runx3 and ThPOK. Further studies are needed to define the roles of CD4CD8 T cells during infection and disease progress.
CONCLUDING REMARKS
Cytotoxic CD4 T cells have not been recognized for a long time since there is a lack of distinct functions, developmental mechanisms, and physiological relevance. Nevertheless, cytotoxic phenotypes of CD4 T cells have been repeatedly reported in human and rodents, mostly CD4CD8 DP IELs in the intestine. Furthermore, there is accumulating evidence showing the presence of cytotoxic CD4 T cell subsets during anti-viral (38-40) and anti-tumor immune responses (51, 52). Finally, recent elegant studies provide us unequivocal answers for the cytotoxic CD4 T cells as a distinct, independent subtype of effector CD4 T cells, which are derived by the unique modulation of transcription factors that drive their development and functional differentiation (5-7) . Although the precise role of CD4CD8 DP IELs and the relevance of their cytolytic phenotypes in vivo are not understood yet, the identification of a new CD4 subset and novel developmental program will improve our understanding on the functional differentiation of effector T cells. New insights gained from these studies will contribute to the identification of new targets for the design of new therapies to prevent and cure infection and Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22, 317-328
